FDA Drug Recalls

Recalls / Class II

Class IID-0075-2024

Product

TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Fruit flavor, Chewable Tablets, packaged in 160-count bottles, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0118-14, UPC 3-0766-0746-10-2

Brand name
Tums
Generic name
Calcium Carbonate
Active ingredient
Calcium Carbonate
Route
Oral
NDCs
0135-0118, 0135-0180, 0135-0181, 0135-0228, 0135-0540
FDA application
M001
Affected lot / code info
Lot #: HV6B, Exp. Date 9/30/2027

Why it was recalled

Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Recalling firm

Firm
GlaxoSmithKline Consumer Healthcare Holdings LLC
Manufacturer
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
320 S Broadway, N/A, Saint Louis, Missouri 63102-2800

Distribution

Quantity
N/A
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2022-12-02
FDA classified
2023-10-27
Posted by FDA
2023-11-08
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0075-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Tums · FDA Drug Recalls